A prodrug is an inactive compound that can be metabolized in the body to produce an active drug. Catalysts can be designed to convert prodrugs into their active forms specifically in diseased tissues, improving the precision of therapies. For example, enzyme catalysts can be targeted to cancer cells to convert prodrugs into active chemotherapeutic agents directly at the tumor site.